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Planarians in pharmacology:
parthenolide is a specific behavioral antagonist of cocaine
in the planarian Girardia tigrina
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MATTHEW TENAGLIA1, CLINITA RANDOLPH1, DHARINI KOTTURU1, CHRISTOPHER TALLARIDA3,
DANIEL BACH1, GALIA WILK1, SCOTT RAWLS4 and ROBERT B. RAFFA3
1
Department of Biology, West Chester University, West Chester, 2Department of Psychology, West Chester
University, West Chester, 3Department of Pharmaceutical Sciences, Temple University School of Pharmacy,
Philadelphia and 4Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA

ABSTRACT Planarians are traditional animal models in developmental and regeneration biology.
Recently, these organisms are arising as vertebrate-relevant animal models in neuropharmacology. Using an adaptation of published behavioral protocols, we have described the alleviation of
cocaine-induced planarian seizure-like movements (pSLM) by a naturally-occurring sesquiterpene
lactone, parthenolide. Interestingly, parthenolide does not prevent the expression of pSLM induced
by amphetamines; in vertebrates, amphetamines interact with the same protein target as cocaine.
Parthenolide is also unable to prevent pSLM elicited by the cholinergic compounds nicotine and
cytisine or by the glutamatergic agents L- or D- glutamic acid or NMDA. Thus, we conclude that
parthenolide is a specific anti-cocaine agent in this experimental organism.
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Introduction
Planarians are one of the best-characterized animal models in
developmental biology and regeneration research (Newmark and
Sánchez Alvarado, 2002) and are currently being rediscovered
as a very useful animal model in neuropharmacology (Buttarelli et
al., 2008; Raffa and Rawls, 2008). Planarians are the first extant
example of organisms displaying cephalization, including a primitive
brain, sometimes referred to as cerebral ganglia, with many features
in common with vertebrate nervous systems, such as multipolar
neurons and dendritic spines (Sarnat and Netsky, 1985). Additionally, nearly every neurotransmitter found in mammals is present in
planarians (Buttarelli et al., 2008; Ribeiro et al., 2005). One of the
most interesting properties of this class of organisms is their remarkable capacity for regeneration, including the complete regeneration
of their cerebral ganglia upon decapitation (Cebrià, 2007; Cebrià
et al., 2002; Gentile et al., 2011). Working with this organism has
several practical advantages. They are commercially available at
very low cost and are very easily kept in the laboratory. No special
equipment such as incubators, etc., is necessary. Additionally, the
genome of a planarian species (Schmidtea mediterranea) has
been sequenced (Robb et al., 2008), which will undoubtedly help

to understand these organisms at the molecular level.
Two specific planarian behavioral endpoints have proven useful
in pharmacological experiments: the observation of changes in
motility (Raffa et al., 2001) and the induction of planaria seizure-like
movements (pSLM; Rawls et al., 2011; Fig. 1A). Both responses
are easily quantified and have been used to study the effect of a
wide variety of psychoactive agents and abused drugs (Raffa and
Rawls, 2008; Rawls, 2011).
Parthenolide (Fig. 1B) is the active component of the feverfew
plant (T. parthenium), used to treat migraines. This compound
has several known biochemical effects, including the inhibition of
serotonin type II receptors (Weber et al., 1997) and the enhancement of NF-kB transcription factor function (Kang et al., 2002).
Also, parthenolide displays anti-inflammatory effects and inhibits
Ikappa-B kinases (Kwok et al., 2001).
Parthenolide and related compounds have been shown (1) to
prevent the expression of cocaine-induced behaviors in planarians,
such as motility decrease and seizure-like hyperkinesias (Pagán
Abbreviations used in this paper: DAT, dopamine transporter; MAT, monoamine transporter; NET, norepinephrine transporter; NMDA, N-Methyl-D-Aspartate; pSLM,
planarian seizure-like movements; SERT, serotonin transporter.
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et al., 2008) and (2) to prevent the expression of withdrawal-like
behaviors induced by cocaine (Rowlands and Pagán, 2008). The
lactone moiety of the parthenolide molecule is essential for its
cocaine-antagonist properties (Pagán et al., 2008). Further work
established that the lactone moiety with a 4-methyl tail is sufficient to prevent the motility decrease induced by cocaine (Baker
et al., 2011). Significantly, similar results have been observed in
vertebrates. Parthenolide alleviates the cocaine-induced effects
on spontaneous firing of dopaminergic neurons in the ventral
tegmental area of rats (Schwarz et al., 2011).
Here we report that parthenolide prevents the pSLMs induced
by cocaine but not the hyperkinesia induced by amphetamines,
the cholinergic ligands nicotine and cytisine, or the glutamatergic
ligands L- of D-glutamic acid and NMDA. These results suggest
that parthenolide is a specific behavioral antagonist for cocaine in
our experimental conditions.

induction of cocaine-induced pSLM, as described before (Pagán
et al., 2008). Interestingly, parthenolide did not alleviate the behavioral response induced by amphetamines (Fig. 1E). However,
please note that even though the global ANOVA p-values does
not indicate a statistical difference between the worms exposed
to amphetamine and the worms exposed to amphetamine/parthenolide in the whole curves, parthenolide significantly reduces the
incidence of pSLM at the highest amphetamine concentration (10
mM). Also, parthenolide did not prevent the expression of pSLM
in response to the cholinergic agents nicotine and cytisine (Fig.
2 A,B) or the glutamatergic ligands L- glutamic acid, D-glutamic
acid or NMDA (Fig. 2 C,D,E).

Discussion

The negative results of parthenolide against all tested compounds except cocaine indicate a very important property of
Results
parthenolide, specificity. In clinical pharmacology, one of the main
problems associated with medications are side effects, which are
Fig. 1C shows that parthenolide up to a concentration of 50 mM
brought about by the interaction of a particular drug with multiple
does not induce significant pSLMs. This is consistent with previous
targets (Sheridan, 2003).
reports, which show that at this concentration, parthenolide does not
The accepted target for cocaine and amphetamines is the
seem to produce any behavioral effects on the planarians (Pagán
monoamine transporter (MAT) superfamily, which includes the
et al., 2008; Rowlands and Pagán, 2008). Based on this, we used
dopamine transporter (DAT), the serotonin transporter (SERT)
parthenolide at a concentration of 50 mM in all subsequent experiand the norepinephrine transporter (NET) (Torres et al., 2003).
ments. Fig. 1D shows that that 50 mM parthenolide prevents the
The main function of the MATs is to regulate neurotransmitter
reuptake to the presynaptic terminal, hence
regulating neurotransmission (Zahniser and
A
C
Doolen, 2001). Neurotransmitter reuptake by
specialized transporters was proposed as an
inactivation mechanism as early as 50 years
ago using radiolabeled noradrenaline (Hertting
and Axelrod, 1961). The effect of cocaine in
noradrenaline reuptake was also demonstrated
B
using the same technique (Hertting et al., 1961).
Since then, this inactivation mechanism has
been demonstrated in many neurotransmitter
systems (Torres et al., 2003). When abused
drugs such as cocaine and amphetamine interact with the DAT, the dopamine concentration
D
E
increases in the synaptic cleft; this increase
causes a direct hyperactivation of postsynaptic
dopamine receptors as well as extrasynaptic
dopamine autoreceptors (Callier et al., 2003).
In fact, one of the main roles of the DAT seems
to be the regulation of dopamine spillover to
these autoreceptors (Cragg and Rice, 2004).
In humans, the main target for cocaine and
amphetamine is the DAT (Uhl et al., 2002).
Interestingly, DAT-knockout rodents are still
sensitive to cocaine through increased participaFig. 1. Effect of parthenolide against cocaine and amphetamine. (A) Representative planarian tion of the NET and SERT in this process (Hall
seizure-like movement. The white bar is 1 cm long. (B) Parthenolide structure. (C) Parthenolide et al., 2004).
does not induce significant pSLMs. Each bar is the average of 4 worms. (D) Cocaine-induced
In light of this information, our results showpSLMs in the presence and in the absence of 50 mM parthenolide. (E) Amphetamine-induced
ing that parthenolide prevented the behavioral
pSLMs in the presence and in the absence of 50 mM parthenolide. Each bar is the average of
4-8 worms. The error bars represent the standard error of the mean. The number at the upper effects of cocaine but not amphetamine was
right corner of (D,E) represent the p-values generated by two-way ANOVA. The asterisks over unexpected, since cocaine and amphetamines
some of the bars indicate significant difference between the column pairs (“*”< 0.05; “**” both interact with neurotransmitter transporters,
albeit through different mechanisms. Cocaine
< 0.01) via a Bonferroni post-test.
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withdrawal-like behavior (Sacavage et al., 2008).
In a broader context, this work highlights the usefulness
of planarians as an important animal model in pharmacology.
In addition to the multiple advantages of using planarians
described above, this model has been demonstrated to be
relevant to mammalian pharmacology (Schwarz, 2011).
Furthermore, since they can be studied all the way from
molecular biology to behavior, these organisms will likely
be developed as important tools in drug discovery research.

Materials and Methods

Fig. 2. Parthenolide does not display behavioral antagonism against
cholinergic and glutamatergic
compounds. Parthenolide does not
prevent the expression of pSLMs
induced by the cholinergic compounds
nicotine (A) and cytisine (B) or by the
glutamatergic compounds L-glutamic
acid (C), D-glutamic acid (D) or NMDA
(E). The number at the upper right corner of each graph represent the p-values
generated by two-way ANOVA. Each bar is the average of 5-10 worms. The error
bars represent the standard error of the mean.

is a reuptake blocker, preventing the transport of the neurotransmitter back to the presynaptic site; amphetamine is considered
a “releaser”, which acts as a false substrate of the transporter
(Riddle et al., 2005). In both cases, the net result is the abnormal
increase of neurotransmitter molecules in the synaptic cleft, which
accounts for the drug’s psychoactive properties (Iversen, 2006;
Sager and Torres, 2011).
Using vertebrate pharmacology as a point of reference, our
results suggests that parthenolide prevents the pSLM induced by
cocaine by inhibiting an interaction with dopaminergic systems.
However, this is not consistent with the amphetamine results
(Fig. 1E) or by the fact that no significant pSLMs are detected
when exposing the worms to a dopamine concentration of 1 mM
(data not shown). Interestingly, preliminary results with another
planarian species, Dugesia dorotocephala, seem to indicate that
parthenolide alleviates amphetamine-induced pSLM (Rawls et
al., unpublished data). A possible interpretation is that in planarians, any catecholamine responses are modulated by compounds
such as norepinephrine, octopamine or tyramine, as opposed to
dopamine. Another implication of our results is that the pSLM are
induced by cocaine/amphetamines and by cholinergic/glutamatergic compounds by interacting with different protein targets.
This is amenable to pharmacological dissection of these distinct
mechanisms.
In future experiments, we will study the effect of parthenolide
against cocaine and amphetamine-like compounds in planarian
behavior using paradigms such as conditioned place preference
(Rawls et al., 2011), cross-sensitization (Rawls et al., 2010) and

Girardia tigrina were purchased from Ward’s (Rochester, NY).
The tested compounds were obtained from Sigma-Aldrich (St. Louis,
MO) or Tocris (Ellisville, MO). General laboratory materials were
purchased from Fisher Scientific (Suwanee, GA). All graphs and
statistical procedures were done using the Prism software package
(GraphPad Inc., La Jolla, CA). The experiments were carried out at
room temperature using artificial pond water (APW, NaCl, 6 mM;
NaHCO3, 0.1 mM; CaCl2, 0.6 mM). Dimethylsulfoxide (DMSO) at
a concentration of 0.1% was present in all experimental solutions
as a solubility-aiding agent for parthenolide. At this concentration,
DMSO does not induce any observable behavioral or toxic effects
in planarians (Pagán et al., 2006).
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